Coloplast A/S (CLPBY)
OTCMKTS · Delayed Price · Currency is USD
7.54
-0.05 (-0.66%)
At close: Nov 9, 2026
Coloplast Financials Overview
Financials in millions DKK. Fiscal year is October - September.
Millions DKK. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Sep '26 Sep 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Revenue Revenue Growth | 28,941 | 28,941 | 27,874 | 27,030 | 24,500 | 22,579 |
Revenue Growth | 3.83% | 3.83% | 3.12% | 10.33% | 8.51% | 16.23% |
Gross Profit Gross Profit Growth | 19,246 | 19,246 | 18,945 | 18,269 | 16,328 | 15,529 |
Operating Income Operating Income Growth | 7,447 | 7,447 | 7,721 | 7,309 | 6,849 | 6,919 |
Net Income Net Income Growth | 3,074 | 3,074 | 3,636 | 5,052 | 4,783 | 4,706 |
Earnings Per Share EPS Growth | 13.64 | 13.64 | 16.13 | 22.46 | 22.20 | 22.11 |
EPS Growth | -15.45% | -15.45% | -28.18% | 1.17% | 0.41% | -2.30% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Sep '26 Sep 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Ostomy Care Ostomy Care Growth | 10,282 | 10,282 | 9,897 | 9,545 | 9,024 | 8,620 |
Continence Care Continence Care Growth | 9,442 | 9,442 | 8,984 | 8,540 | 7,958 | 7,643 |
Voice and Respiratory Care Voice and Respiratory Care Growth | 2,419 | 2,419 | 2,280 | 2,110 | 1,939 | 1,203 |
Interventional Urology Interventional Urology Growth | 2,949 | 2,949 | 2,784 | 2,775 | 2,674 | 2,424 |
Advanced Wound Dressings Advanced Wound Dressings Growth | 2,685 | 2,685 | 2,675 | 3,034 | 2,830 | 2,689 |
Biologics Biologics Growth | 1,164 | 1,164 | 1,254 | 1,026 | 75 | - |
Revenue (Total) Revenue (Total) Growth | 28,941 | 28,941 | 27,874 | 27,030 | 24,500 | 22,579 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Sep '26 Sep 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Cash & Investments Cash & Investments Growth | 511 | 511 | 947 | 788 | 911 | 633 |
Total Debt Total Debt Growth | 21,518 | 21,518 | 22,639 | 22,629 | 19,567 | 18,708 |
Net Cash (Debt) Net Cash Growth | -21,007 | -21,007 | -21,692 | -21,841 | -18,656 | -18,075 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -93.20 | -93.20 | -96.24 | -97.11 | -86.57 | -84.94 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Sep '26 Sep 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 8,006 | 8,006 | 6,645 | 2,766 | 4,226 | 5,099 |
Capital Expenditures CapEx Growth | -1,386 | -1,386 | -1,306 | -1,166 | -1,020 | -927 |
Free Cash Flow Free Cash Flow Growth | 6,620 | 6,620 | 5,339 | 1,600 | 3,206 | 4,172 |
Free Cash Flow Growth | 23.99% | 23.99% | 233.69% | -50.09% | -23.15% | -4.55% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Sep '26 Sep 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Gross Margin | 66.50% | 66.50% | 67.97% | 67.59% | 66.64% | 68.78% |
Operating Margin | 25.73% | 25.73% | 27.70% | 27.04% | 27.96% | 30.64% |
Pretax Margin | 13.30% | 13.30% | 22.09% | 23.66% | 24.59% | 27.14% |
Profit Margin | 10.62% | 10.62% | 13.04% | 18.69% | 19.52% | 20.84% |
FCF Margin | 22.87% | 22.87% | 19.15% | 5.92% | 13.09% | 18.48% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 10, 2026 | Sep '26 Sep 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.347 | 23.000 | 23.000 | 22.000 | 21.000 | 20.000 |
Dividend Per Share Growth | -2.99% | 0% | 4.54% | 4.76% | 5.00% | 5.26% |
Dividend Yield | 4.60% | 5.51% | 4.24% | 2.52% | 2.81% | 2.58% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 10, 2026 | Sep '26 Sep 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
PE Ratio | 36.83 | 30.61 | 33.63 | 38.97 | 35.12 | 35.00 |
P/FCF Ratio | 16.66 | 14.21 | 22.90 | 123.04 | 52.39 | 39.48 |
PS Ratio | 3.81 | 3.25 | 4.39 | 7.28 | 6.86 | 7.30 |